HCW Biologics (HCWB) Accumulated Depreciation & Amortization (2020 - 2024)
HCW Biologics (HCWB) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $3.7 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 21.26% year-over-year to $3.7 million, compared with a TTM value of $3.7 million through Dec 2024, up 21.26%, and an annual FY2024 reading of $3.7 million, up 21.26% over the prior year.
- Accumulated Depreciation & Amortization was $3.7 million for Q4 2024 at HCW Biologics, up from $3.0 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $3.7 million in Q4 2024 and bottomed at $1.1 million in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $2.3 million, with a median of $2.2 million recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization soared 49.24% in 2021, then increased 21.26% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $1.1 million in 2020, then skyrocketed by 49.24% to $1.6 million in 2021, then surged by 35.79% to $2.2 million in 2022, then skyrocketed by 35.52% to $3.0 million in 2023, then rose by 21.26% to $3.7 million in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for HCWB at $3.7 million in Q4 2024, $3.0 million in Q4 2023, and $2.2 million in Q4 2022.